Today, I was working in my pre-reg store, due to the weather, it was rather slow.
So I managed to spare some time to listen to the sales rep from Chiesi, promoting the relatively new Fostair inhalers.
Well.. this pink inhaler has been available for awhile now, but I guess not many doctors are prescribing it yet. So the company is trying very hard to sell their product through pharmacies, hoping we pharmacist can influence patients and doctors of the benefits of Fostair compared to Symbicort and Seretide inhalers (the combination inhalers).
At first I was just entertaining the sales rep, after listening to her presentation, I actually gave it a thought, and had a go at reading the leaflets to see whats so great about fostair.
Well here are some information gathered :-
- It is the first and only metered-dose inhaler combining beclomethasone and formoterol
- Comparable efficacy to symbicort and seretides
- Fast onset of bronchodilation within 1-3 minutes, and is the only formoterol containing combination in MDI
- It is now licensed to be used with aerochamber plus spacer
- Fostair is cheaper then Seretide and Symbicort (the latter being most expensive)
- Only combination inhaler that has extra fine particles , delivers 31% medication to lungs compared to 10-20% for non-extra fine MDI (similar to QVAR)
- It is a solution formulation, it delivers uniform dose from the 1st to the final actuation, so patient doesn’t have to shake before use.
The only disadvantages are it needs to be kept in the fridge before use, once removed from fridge shelf life is 5 months, which is still pretty long considering each inhaler provides approx 1 month supply if BD dosing. Also it is not like Symbicort – SMART trial, where it is licensed to be used as a reliever as well as a preventor, Fostair is not licensed to be used as a reliever, but it does open up the airways faster, due to the extra fine particles.
I rarely see it on prescriptions, as it is still fairly new. Licensed to be used with aerochamber plus spacer only recently granted. But so far, for those who has been on Fostair has given positive feedback. I guess, it would be an alternative to think about when doing MUR, if a patient doesn’t get on with symbicort or seretide, or still dont get maximal benefit, then perhaps Fostair would be an alternative before stepping up to step 4 or 5. Also it is much cheaper than symbicort, one more thing as well, with symbicort(turbohaler), patients need to breathe in harder to get the drug into the lungs. The in-check dial device is a useful tool to determine whether the type of inhalers are suitable for the patient.
